Sensitive ASX Announcement

ANTIVIRAL ACTIVITY ENHANCED IN HIV/HCV GENOTYPE 3 PATIENTS

Published: 25/10/13, 10:22am (AEST)3 pages
Biotron Limited
BIT:ASXHealthcare

Recent BIT Announcements

Price Sensitive only